These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28743508)

  • 41. Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials.
    Matralis AN; Afantitis A; Aidinis V
    Med Res Rev; 2019 May; 39(3):976-1013. PubMed ID: 30462853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel imidazo[1,2-a]pyridine derivatives as potent ATX allosteric inhibitors: Design, synthesis and promising in vivo anti-fibrotic efficacy in mice lung model.
    Lei H; Li Z; Li T; Wu H; Yang J; Yang X; Yang Y; Jiang N; Zhai X
    Bioorg Chem; 2022 Mar; 120():105590. PubMed ID: 34998121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors.
    Vrontaki E; Melagraki G; Kaffe E; Mavromoustakos T; Kokotos G; Aidinis V; Afantitis A
    Curr Med Chem; 2016; 23(17):1708-24. PubMed ID: 26997151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
    Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
    Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and promising anti-tumor efficacy of novel imidazo[1,2-a]pyridine derivatives as potent autotaxin allosteric inhibitors.
    Lei H; Wang X; Zhao G; Li T; Cui Y; Wu H; Yang J; Jiang N; Zhai X
    Eur J Med Chem; 2022 Jun; 236():114307. PubMed ID: 35436669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes.
    Stylianaki EA; Mouchlis VD; Magkrioti C; Papavasileiou KD; Afantitis A; Matralis AN; Aidinis V
    Bioorg Med Chem Lett; 2024 May; 103():129690. PubMed ID: 38447786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of Novel Indole-Based Allosteric Highly Potent ATX Inhibitors with Great
    Lei H; Guo M; Li X; Jia F; Li C; Yang Y; Cao M; Jiang N; Ma E; Zhai X
    J Med Chem; 2020 Jul; 63(13):7326-7346. PubMed ID: 32479084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors.
    Magkrioti C; Kaffe E; Stylianaki EA; Sidahmet C; Melagraki G; Afantitis A; Matralis AN; Aidinis V
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling.
    Keune WJ; Hausmann J; Bolier R; Tolenaars D; Kremer A; Heidebrecht T; Joosten RP; Sunkara M; Morris AJ; Matas-Rico E; Moolenaar WH; Oude Elferink RP; Perrakis A
    Nat Commun; 2016 Apr; 7():11248. PubMed ID: 27075612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Green Synthesis and Molecular Docking of Thiazolyl-thiazole Derivatives as Potential Cytotoxic Agents.
    Gomha SM; Abdelaziz MR; Abdel-Aziz HM; Hassan SA
    Mini Rev Med Chem; 2017; 17(9):805-815. PubMed ID: 28019641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents.
    Anuradha ; Patel S; Patle R; Parameswaran P; Jain A; Shard A
    Eur J Pharm Sci; 2019 Jun; 134():20-30. PubMed ID: 30965082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and discovery of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4-phenyl)thiazole derivatives as cardiotonic agents via inhibition of PDE3.
    Duan LM; Yu HY; Li YL; Jia CJ
    Bioorg Med Chem; 2015 Sep; 23(18):6111-7. PubMed ID: 26319621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
    Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
    Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase.
    Zhu J; Han L; Diao Y; Ren X; Xu M; Xu L; Li S; Li Q; Dong D; Huang J; Liu X; Zhao Z; Wang R; Zhu L; Xu Y; Qian X; Li H
    J Med Chem; 2015 Feb; 58(3):1123-39. PubMed ID: 25580811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virtual screening approaches for the identification of non-lipid autotaxin inhibitors.
    Parrill AL; Echols U; Nguyen T; Pham TC; Hoeglund A; Baker DL
    Bioorg Med Chem; 2008 Feb; 16(4):1784-95. PubMed ID: 18036821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
    Ismail MA; Tratrat C; Haroun MG
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1331-45. PubMed ID: 22957723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S; Shang R; Shi L; Wan DC; Lin H
    Eur J Med Chem; 2014 Jun; 81():237-44. PubMed ID: 24844448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors.
    Song JU; Choi SP; Kim TH; Jung CK; Lee JY; Jung SH; Kim GT
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1254-8. PubMed ID: 25704891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors.
    Zhou M; Ning C; Liu R; He Y; Yu N
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3200-3. PubMed ID: 23639537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery and optimization of boronic acid based inhibitors of autotaxin.
    Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H
    J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.